Drug Pipeline

AZ-3102 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
3
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
3
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07054515 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in… Niemann-Pick Type C Disease Recruiting
NCT07082543 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in… Gangliosidoses, GM2 Recruiting
NCT07082725 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in… Niemann-Pick Type C Disease Recruiting
Phase 2
NCT07399704 A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With… GM2 Gangliosidosis Recruiting
Sponsors Running AZ-3102 Trials
Azafaros A.G. (4)
Get alerts when AZ-3102 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free